Form EFFECT CymaBay Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 28, 2024 |
| Accession Number: | 0001193125-24-075270 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TELUS Digital to Host Agentforce Industry Sessions and Exclusive Events at Hotel Zetta During Dreamforce 2026
- Fixing of coupon rates - Nykredit Realkredit A/S
- Cango Inc.'s AI Subsidiary, EcoHash, Announces Operational Milestones: Completes Dedicated AI Infrastructure Modification at Georgia Facility and Begins Commercial GPU Compute Services Using First Bat
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
